1. Home
  2. ARAY vs OPP Comparison

ARAY vs OPP Comparison

Compare ARAY & OPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARAY
  • OPP
  • Stock Information
  • Founded
  • ARAY 1990
  • OPP 2010
  • Country
  • ARAY United States
  • OPP United States
  • Employees
  • ARAY N/A
  • OPP N/A
  • Industry
  • ARAY Medical/Dental Instruments
  • OPP Finance/Investors Services
  • Sector
  • ARAY Health Care
  • OPP Finance
  • Exchange
  • ARAY Nasdaq
  • OPP Nasdaq
  • Market Cap
  • ARAY 180.0M
  • OPP 200.8M
  • IPO Year
  • ARAY 2007
  • OPP N/A
  • Fundamental
  • Price
  • ARAY $2.24
  • OPP $8.35
  • Analyst Decision
  • ARAY Strong Buy
  • OPP
  • Analyst Count
  • ARAY 1
  • OPP 0
  • Target Price
  • ARAY $9.00
  • OPP N/A
  • AVG Volume (30 Days)
  • ARAY 669.1K
  • OPP 108.0K
  • Earning Date
  • ARAY 01-29-2025
  • OPP 01-01-0001
  • Dividend Yield
  • ARAY N/A
  • OPP 14.41%
  • EPS Growth
  • ARAY N/A
  • OPP N/A
  • EPS
  • ARAY N/A
  • OPP N/A
  • Revenue
  • ARAY $444,204,000.00
  • OPP N/A
  • Revenue This Year
  • ARAY $6.64
  • OPP N/A
  • Revenue Next Year
  • ARAY $5.69
  • OPP N/A
  • P/E Ratio
  • ARAY N/A
  • OPP N/A
  • Revenue Growth
  • ARAY N/A
  • OPP N/A
  • 52 Week Low
  • ARAY $1.40
  • OPP $7.26
  • 52 Week High
  • ARAY $2.99
  • OPP $8.83
  • Technical
  • Relative Strength Index (RSI)
  • ARAY 60.03
  • OPP 45.64
  • Support Level
  • ARAY $2.04
  • OPP $8.29
  • Resistance Level
  • ARAY $2.34
  • OPP $8.60
  • Average True Range (ATR)
  • ARAY 0.15
  • OPP 0.11
  • MACD
  • ARAY 0.03
  • OPP -0.00
  • Stochastic Oscillator
  • ARAY 82.76
  • OPP 28.57

About ARAY Accuray Incorporated

Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.

About OPP RiverNorth/DoubleLine Strategic Opportunity Fund Inc.

RiverNorth/DoubleLine Strategic Opportunity Fund Inc is a closed-end management investment company. The company's investment objective is to seek current income and overall total return.

Share on Social Networks: